USPTO serial 79369434
ONLY ONO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 6, 2024
- Examiner
- CANTONE, KERI H
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ONLY ONO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Perla M. Kuhn
Perla M. Kuhn Fox Rothschild LLP997 Lenox Drive, Building 3Princeton Pike Corporate CenterLawrenceville, NJ 08648-2311Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes for treating cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; general and topical anesthetic, sedative and analgesic drugs; vaccines | ACTIVE | — |
| 044 | Provision of medical and medical pharmaceutical information via the Internet; provision of medical information relating to medical benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; advisory services relating to pharmaceutical products; provision of information on pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic or treatment purposes; medical testing; medical consultancy and diagnosis via the Internet; online medical counseling services; remote monitoring of patient health status for medical conditions; remote monitoring of medical data for medical diagnosis and treatment; analysis and provision of clinical data of patients for medical diagnostic or treatment purposes; provision of medical information; physical examination; providing medical information about pharmaceuticals, medical services or health; consultancy services relating to medical services, pharmaceuticals, health or dispensing of medications; consultancy, advisory and provision of information relating to health care; managed health care services; provision of records of personal health information data such as weight, body fat, body temperature, number of steps, sleeping hours and blood pressure; nursing care; rental of medical apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ONO PHARMACEUTICAL CO., LTD.
- Other trademarks owned by ONO PHARMACEUTICAL CO., LTD.
- Other trademarks owned by ONO PHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named ONLY ONO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 30, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 30, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 6, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 6, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 15, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 15, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 15, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 15, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 19, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 17, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 11, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |